These 3 ASX shares have the ingredients of long-term compounders

These shares could be well-positioned for growth in the future. Let's see why.

Some of the best long-term investments are businesses that can keep growing without having to reinvent themselves every few years.

They usually have strong competitive positions, plenty of room to grow, and the ability to reinvest profits at attractive returns.

With that in mind, here are three ASX shares that I think have many of the ingredients needed to compound shareholder wealth over time.

Two colleagues looking at a graph and comparing share prices.

Image source: Getty Images

Life360 Inc (ASX: 360)

The first share is Life360. Its family safety app has become a big part of everyday life for millions of families, offering location sharing, driving reports, crash detection, emergency features, and a growing range of other services.

What I like about Life360 is how much more it could potentially get from the audience it has already built.

Most users access the platform for free, which gives the company a huge pool of people that could eventually move onto paid memberships. At the same time, Life360 can keep adding reasons for families to spend more through new services and higher-value subscriptions.

There is also a significant international opportunity. The US is its most developed market today, but there is no obvious reason why its overseas business couldn't eventually become much larger.

If Life360 can keep growing its audience while getting better at monetising it, I think the company could be considerably bigger in a decade.

Pro Medicus Ltd (ASX: PME)

Another ASX share I think has excellent long-term prospects is Pro Medicus.

Its Visage imaging platform is used by major hospitals and healthcare groups, particularly in the United States, to manage and interpret huge volumes of medical images.

And those volumes aren't standing still. Healthcare systems are performing more scans, while radiologists are being asked to deal with increasingly heavy workloads. Software that allows them to work faster and more efficiently is therefore becoming increasingly valuable.

This has helped Pro Medicus win a string of major contracts in the US, and I think there is plenty more market share available to take.

I also like the economics of the business. Once another customer comes onto Visage, Pro Medicus doesn't need to build factories or hire thousands of employees to support the extra revenue.

That scalability means continued market share gains could translate into very strong profit growth over the long term.

WiseTech Global Ltd (ASX: WTC)

A final ASX share with the potential to compound for many years is WiseTech Global.

Its CargoWise platform helps freight forwarders and logistics companies manage everything from customs and warehousing to shipping, documentation, and compliance.

Global logistics is complicated, which works in WiseTech's favour. Large customers can build CargoWise deep into their operations, and once that happens, replacing it isn't necessarily a simple exercise. This gives WiseTech an opportunity to grow alongside its customers and gradually provide them with more functionality through the same platform.

The company has also spent heavily on expanding what CargoWise can do, both through internal development and acquisitions.

Governance concerns are worth highlighting, because poor governance can ultimately undermine even a very good business.

But if WiseTech can put those issues behind it and CargoWise continues becoming an increasingly important part of global logistics, I think the company could have a lot more growth ahead of it.

Motley Fool contributor James Mickleboro has positions in Life360, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360 and WiseTech Global. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Two work colleagues looking at a laptop and discussing something.
Growth Shares

If I could own just one ASX share for the next decade, these 5 would make my shortlist

Let's see which shares made the cut.

Read more »

Watering can pouring water on increasing piles of coins with green plants on them and a piggy bank and coins on the table.
Growth Shares

My $5k bullish growth play: 3 exciting ASX stocks I just bought for retirement

I’m excited by what these stocks could achieve in the future.

Read more »

Hourglass in a hand with white lines and dollar signs.
Growth Shares

2 top ASX shares to buy and hold for the next decade

I think these businesses have a very exciting future.

Read more »

Two smiling colleagues looking at a tablet in a data centre.
Growth Shares

Where I'd invest $10,000 in ASX growth shares

These shares have strong growth outlooks. Let's get to know them better.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Growth Shares

2 ASX growth shares I think could surprise investors by 2030

These two shares could have bucketloads of growth ahead of them.

Read more »

Happy businessman fist pumping while looking at a tablet.
Growth Shares

Why I think these shares could return more than the ASX 200 by 2030

Beating the market isn't easy, but I think these companies have qualities that could make it happen.

Read more »

Green arrow going up on a stock market chart, symbolising a rising share price.
Growth Shares

2 ASX shares tipped to grow up to 142% in the next 12 months

Analysts think these stocks are poised to deliver big returns.

Read more »

Man reading his emails on a laptop while relaxing on a beach.
Growth Shares

3 ASX growth shares I think are no-brainer buys

There are good reasons why I am bullish on these shares.

Read more »